Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2

Kristina Lorenz1, Martin J Lohse, Ursula Quitterer

  • 1Institut für Pharmakologie und Toxikologie, Versbacher Strasse 9, D-97078 Würzburg, Germany.

Nature
|December 5, 2003
PubMed

Insights

Raf kinase inhibitor protein (RKIP) inhibits G-protein-coupled receptor kinase 2 (GRK-2). Upon G-protein-coupled receptor stimulation, RKIP switches targets to block GRK-2, enhancing cellular signaling and adaptation.

Area of Science:

  • Cellular signaling
  • Signal transduction pathways
  • Molecular biology

Background:

  • Feedback inhibition is crucial for signal transduction and cellular adaptation.
  • G-protein-coupled receptor kinase 2 (GRK-2) is a key regulator of G-protein-coupled receptors (GPCRs), controlling their activity and internalization.
  • Dysregulation of GRK-2 is implicated in cardiovascular disorders like hypertension and heart failure.

Purpose of the Study:

  • To identify physiological mechanisms controlling G-protein-coupled receptor kinase 2 (GRK-2) activity.
  • To investigate the role of Raf kinase inhibitor protein (RKIP) as a regulator of GRK-2.
  • To elucidate a novel feedback inhibition mechanism in G-protein-coupled receptor signaling.

Main Methods:

  • Investigated the interaction between RKIP and GRK-2 following GPCR stimulation.
  • Utilized protein kinase C (PKC) phosphorylation assays to determine the trigger for RKIP target switching.
  • Examined the functional consequences of RKIP-GRK-2 interaction in cardiomyocytes.

Main Results:

  • Raf kinase inhibitor protein (RKIP) was identified as a physiological inhibitor of GRK-2.
  • Upon GPCR stimulation, RKIP dissociates from Raf-1 to bind and inhibit GRK-2.
  • PKC-dependent phosphorylation of RKIP at serine 153 mediates this target switch.
  • This mechanism enhances GPCR signaling by simultaneously inhibiting GRK-2 and relieving inhibition of Raf-1.
  • Downregulation of RKIP in cardiomyocytes impairs beta-adrenergic signaling and contractile function.

Conclusions:

  • RKIP acts as a critical feedback inhibitor of GRK-2, revealing a new regulatory principle in signal transduction.
  • The RKIP-GRK-2 axis provides a mechanism to fine-tune GPCR signaling responses.
  • This pathway has significant implications for understanding and potentially treating cardiovascular diseases associated with GRK-2 dysregulation.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
5.7K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.3K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
15.5K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.3K